DiMartino Jorge 4
4 · Kronos Bio, Inc. · Filed Dec 15, 2021
Insider Transaction Report
Form 4
Kronos Bio, Inc.KRON
DiMartino Jorge
Chief Medical Officer & VP
Transactions
- Sale
Common Stock
2021-12-13$12.82/sh−250$3,206→ 117,535 total - Sale
Common Stock
2021-12-13$12.36/sh−16,152$199,687→ 117,785 total
Footnotes (1)
- [F1]Represents shares sold to satisfy estimated tax withholding obligations upon the settlement of restricted stock units.